Wavegate Corporation Appoints Jeff Cambra as Chief Executive Officer
Lake Charles, LA — February 2, 2026 — Wavegate Corporation, a clinical-stage neuromodulation company advancing next-generation spinal cord stimulation (SCS) technologies, today announced the appointment of Jeff Cambra as Chief Executive Officer.
Mr. Cambra brings more than 28 years of executive leadership experience across medical devices, neuroscience, drug-device combination products, and complex regulated healthcare markets. He has held senior C-level roles spanning general management, commercial strategy, business development, operations, and fundraising, with a proven track record of scaling organizations through pivotal inflection points.
“Jeff is exactly the type of seasoned MedTech leader Wavegate needs as we enter our next phase of growth,” said Erich W. Wolf II, MD, PhD, Founder of Wavegate Corporation. “His depth of experience in building and commercializing complex medical technologies, coupled with his strategic and operational discipline, positions Wavegate to execute decisively as we advance toward clinical and regulatory milestones.”
As CEO, Mr. Cambra will lead Wavegate’s corporate strategy, capital formation, clinical execution, and commercialization planning, working closely with the Board of Directors and executive leadership team. His appointment reflects Wavegate’s focus on strengthening operational leadership as the company progresses its proprietary spinal cord stimulation platform toward clinical validation.
“I am excited to join Wavegate at such a pivotal moment,” said Mr. Cambra. “The company’s technology platform addresses fundamental limitations in today’s neuromodulation systems and has the potential to meaningfully improve patient outcomes. I look forward to working with the Wavegate team to translate this innovation into clinical and commercial success.”
Dr. Wolf, who has served as Wavegate’s Founder and de facto CEO during the company’s formative years, has transitioned into the role of Chief Technology Officer. In this capacity, he will continue to lead Wavegate’s technology vision, intellectual property strategy, and advanced R&D initiatives.
About Wavegate Corporation Wavegate Corporation is a neuromodulation technology company developing advanced spinal cord stimulation systems designed to improve therapeutic efficacy, durability of pain relief, and patient experience. The company integrates proprietary sensing, adaptive control, and data-driven software to address longstanding challenges in chronic pain management.
For more information, visit www.wavegate.us.